Natasha Novikov has extensive work experience in the medical field. Natasha is currently working as a Medical Director at Disc Medicine since January 2022. Prior to that, they held the same role at bluebird bio starting from December 2020. From 2019 to 2020, Natasha worked at Biogen as an Associate Medical Director. Natasha also worked as a Molecular Tumour Board Consultant at Foundation Medicine from November 2018 to April 2019. Before that, they were a Clinical Pathology Resident at Brigham and Women's Hospital from July 2017 to April 2019. Natasha also gained experience as a Postdoctoral Fellow at Massachusetts General Hospital from June 2015 to June 2017. Natasha started their career as an MD/PhD Research Fellow at Weill Cornell Graduate School of Medical Sciences from July 2007 to May 2015 and previously worked as an Undergraduate Research Fellow at Harvard Medical School from 2004 to 2007.
Natasha Novikov completed their Bachelor of Arts in Biochemical Sciences at Harvard University from 2003 to 2007. Natasha then pursued their medical education at the Joan & Sanford I. Weill Medical College of Cornell University, earning their Doctor of Medicine (MD) degree from 2007 to 2015. In addition to their medical studies, from 2009 to 2013, Natasha also pursued a Doctor of Philosophy (PhD) degree in Physiology, Biophysics and Systems Biology at the Weill Cornell Graduate School of Medical Sciences.
January, 2022 - present
Senior Medical Director, Safety & Risk Management Lead at UCB
Medical Director, Denials Management at CorroHealth
Medical Director, CV Renal at Novo Nordisk
Medical Director at Wellspan Health
Medical Director, US Patient Safety at AstraZeneca
Access the worlds's biggest network of public org charts
Learn more